Journal of Integrative Plant Biology,
Journal Year:
2022,
Volume and Issue:
65(2), P. 444 - 467
Published: Dec. 7, 2022
Precise
replacement
of
an
allele
with
elite
controlling
important
agronomic
trait
in
a
predefined
manner
by
gene
editing
technologies
is
highly
desirable
crop
improvement.
Base
and
prime
are
two
newly
developed
precision
systems
which
can
introduce
the
substitution
single
base
install
desired
short
indels
to
target
loci
absence
double-strand
breaks
donor
repair
templates,
respectively.
Since
their
discoveries,
various
strategies
have
been
attempted
optimize
both
editor
(BE)
(PE)
order
improve
precise
efficacy,
specificity,
expand
targeting
scopes.
Here,
we
summarize
latest
development
BEs
PEs,
as
well
applications
plants.
Based
on
these
progresses,
recommend
appropriate
PEs
for
basic
plant
research
Moreover,
propose
perspectives
further
optimization
editors.
We
envision
that
will
become
routine
customized
tools
biological
improvement
near
future.
Clinical Microbiology Reviews,
Journal Year:
2021,
Volume and Issue:
34(3)
Published: May 11, 2021
The
coronavirus
disease
2019
(COVID-19)
pandemic,
caused
by
severe
acute
respiratory
2
(SARS-CoV-2),
has
led
to
millions
of
confirmed
cases
and
deaths
worldwide.
Efficient
diagnostic
tools
are
in
high
demand,
as
rapid
large-scale
testing
plays
a
pivotal
role
patient
management
decelerating
spread.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Jan. 16, 2023
Abstract
Clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)/CRISPR-associated
protein
9
(Cas9)
gene-editing
technology
is
the
ideal
tool
of
future
for
treating
diseases
by
permanently
correcting
deleterious
base
mutations
or
disrupting
disease-causing
genes
with
great
precision
and
efficiency.
A
variety
efficient
Cas9
variants
derivatives
have
been
developed
to
cope
complex
genomic
changes
that
occur
during
diseases.
However,
strategies
effectively
deliver
CRISPR
system
diseased
cells
in
vivo
are
currently
lacking,
nonviral
vectors
target
recognition
functions
may
be
focus
research.
Pathological
physiological
resulting
from
disease
onset
expected
serve
as
identifying
factors
targeted
delivery
targets
gene
editing.
Diseases
both
varied
complex,
choice
appropriate
methods
different
important.
Meanwhile,
there
still
many
potential
challenges
identified
when
targeting
CRISPR/Cas9
treatment.
This
paper
reviews
current
developments
three
aspects,
namely,
type,
vector,
characteristics.
Additionally,
this
summarizes
successful
examples
clinical
trials
finally
describes
possible
problems
associated
applications.
Biologics,
Journal Year:
2021,
Volume and Issue:
Volume 15, P. 353 - 361
Published: Aug. 1, 2021
Abstract:
Clustered
regularly
interspaced
short
palindromic
repeat
(CRISPR)
and
their
associated
protein
(Cas-9)
is
the
most
effective,
efficient,
accurate
method
of
genome
editing
tool
in
all
living
cells
utilized
many
applied
disciplines.
Guide
RNA
(gRNA)
CRISPR-associated
proteins
are
two
essential
components
CRISPR/Cas-9
system.
The
mechanism
contains
three
steps,
recognition,
cleavage,
repair.
designed
sgRNA
recognizes
target
sequence
gene
interest
through
a
complementary
base
pair.
While
Cas-9
nuclease
makes
double-stranded
breaks
at
site
3
pair
upstream
to
protospacer
adjacent
motif,
then
break
repaired
by
either
non-homologous
end
joining
or
homology-directed
repair
cellular
mechanisms.
genome-editing
has
wide
number
applications
areas
including
medicine,
agriculture,
biotechnology.
In
it
could
help
design
new
grains
improve
nutritional
value.
being
investigated
for
cancers,
HIV,
therapy
such
as
sickle
cell
disease,
cystic
fibrosis,
Duchenne
muscular
dystrophy.
technology
also
regulation
specific
genes
advanced
modification
protein.
However,
immunogenicity,
effective
delivery
systems,
off-target
effect,
ethical
issues
have
been
major
barriers
extend
clinical
applications.
Although
becomes
era
molecular
biology
countless
roles
ranging
from
basic
researches
applications,
there
still
challenges
rub
practical
various
improvements
needed
overcome
obstacles.
Keywords:
CRISPR,
Cas-9,
sgRNA,
gene-editing,
mechanism,
Advanced Science,
Journal Year:
2020,
Volume and Issue:
7(6)
Published: Feb. 6, 2020
Abstract
Life
sciences
have
been
revolutionized
by
genome
editing
(GE)
tools,
including
zinc
finger
nucleases,
transcription
activator‐Like
effector
and
CRISPR
(clustered
regulatory
interspaced
short
palindromic
repeats)/Cas
(CRISPR‐associated)
systems,
which
make
the
targeted
modification
of
genomic
DNA
all
organisms
possible.
CRISPR/Cas
systems
are
being
widely
used
because
their
accuracy,
efficiency,
cost‐effectiveness.
Various
classes
developed,
but
extensive
use
may
be
hindered
off‐target
effects.
Efforts
made
to
reduce
effects
CRISPR/Cas9
generating
various
with
high
fidelity
accuracy.
Several
approaches
applied
detect
evaluate
Here,
current
GE
generated
technology,
types
effects,
mechanisms
major
concerns,
outcomes
in
plants
animals
summarized.
The
methods
tools
for
single‐guide
RNA
(sgRNA)
design,
evaluation
prediction
strategies
increase
on‐target
efficiency
mitigate
impact
on
intended
genome‐editing
Plant Biotechnology Journal,
Journal Year:
2020,
Volume and Issue:
18(8), P. 1651 - 1669
Published: April 9, 2020
Summary
Over
the
last
three
decades,
development
of
new
genome
editing
techniques,
such
as
ODM,
TALENs,
ZFNs
and
CRISPR‐Cas
system,
has
led
to
significant
progress
in
field
plant
animal
breeding.
The
system
is
most
versatile
tool
discovered
history
molecular
biology
because
it
can
be
used
alter
diverse
genomes
(e.g.
from
both
plants
animals)
including
human
with
unprecedented
ease,
accuracy
high
efficiency.
recent
scope
have
raised
regulatory
challenges
around
world
due
moral,
ethical,
safety
technical
concerns
associated
its
applications
pre‐clinical
clinical
research,
biomedicine
agriculture.
Here,
we
review
art,
potential
risks
editing.
We
also
highlight
patent
ethical
issues
this
technology
along
frameworks
established
by
various
nations
regulate
CRISPR‐Cas‐modified
organisms/products.
ACS Infectious Diseases,
Journal Year:
2022,
Volume and Issue:
8(9), P. 1758 - 1814
Published: Aug. 8, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
highly
transmissible
and
virulent
human-infecting
that
emerged
in
late
December
2019
Wuhan,
China,
causing
disease
called
(COVID-19),
which
has
massively
impacted
global
public
health
caused
widespread
disruption
to
daily
life.
The
crisis
by
COVID-19
mobilized
scientists
authorities
across
the
world
rapidly
improve
our
knowledge
about
this
devastating
disease,
shedding
light
on
its
management
control,
spawned
development
of
new
countermeasures.
Here
we
provide
an
overview
state
art
gained
last
years
virus
COVID-19,
including
origin
natural
reservoir
hosts,
viral
etiology,
epidemiology,
modes
transmission,
clinical
manifestations,
pathophysiology,
diagnosis,
treatment,
prevention,
emerging
variants,
vaccines,
highlighting
important
differences
from
previously
known
pathogenic
coronaviruses.
We
also
discuss
selected
key
discoveries
each
topic
underline
gaps
for
future
investigations.
Nature Plants,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Feb. 9, 2023
Abstract
Transformation
in
grass
species
has
traditionally
relied
on
immature
embryos
and
therefore
been
limited
to
a
few
major
Poaceae
crops.
Other
transformation
explants,
including
leaf
tissue,
have
explored
but
with
low
success
rates,
which
is
one
of
the
factors
hindering
broad
application
genome
editing
for
crop
improvement.
Recently,
using
morphogenic
genes
Wuschel2
(
Wus2
)
Babyboom
Bbm
successfully
used
Cas9-mediated
mutagenesis,
complex
applications,
requiring
large
numbers
regenerated
plants
be
screened,
remain
elusive.
Here
we
demonstrate
that
enhanced
/
expression
substantially
improves
maize
sorghum,
allowing
recovery
gene
dropouts
targeted
insertion.
Moreover,
maize-optimized
construct,
embryogenic
callus
plantlets
were
produced
eight
spanning
four
subfamilies,
suggesting
this
may
lead
universal
family-wide
method
across
Poaceae.
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Jan. 9, 2024
Abstract
The
CRISPR
system
is
a
revolutionary
genome
editing
tool
that
has
the
potential
to
revolutionize
field
of
cancer
research
and
therapy.
ability
precisely
target
edit
specific
genetic
mutations
drive
growth
spread
tumors
opened
up
new
possibilities
for
development
more
effective
personalized
treatments.
In
this
review,
we
will
discuss
different
CRISPR-based
strategies
have
been
proposed
therapy,
including
inactivating
genes
tumor
growth,
enhancing
immune
response
cells,
repairing
cause
cancer,
delivering
cancer-killing
molecules
directly
cells.
We
also
summarize
current
state
preclinical
studies
clinical
trials
highlighting
most
promising
results
challenges
still
need
be
overcome.
Safety
delivery
are
important
therapy
become
viable
option.
limitations
overcome,
such
as
off-target
effects,
safety,
site.
Finally,
provide
an
overview
opportunities
in
future
directions
development.
change
landscape
research,
review
aims
overcome
realize
potential.